• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病足溃疡合并无可选择的严重肢体缺血患者的特征及预后

Characteristics and Outcome for Persons with Diabetic Foot Ulcer and No-Option Critical Limb Ischemia.

作者信息

Meloni Marco, Izzo Valentina, Da Ros Valerio, Morosetti Daniele, Stefanini Matteo, Brocco Enrico, Giurato Laura, Gandini Roberto, Uccioli Luigi

机构信息

Department of Systems Medicine, University of Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.

Department of Biomedicine and Prevention, University of Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.

出版信息

J Clin Med. 2020 Nov 21;9(11):3745. doi: 10.3390/jcm9113745.

DOI:10.3390/jcm9113745
PMID:33233329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7700155/
Abstract

The study aimed to evaluate clinical and vascular characteristics, as well as outcomes, for diabetic persons with foot ulceration and no-option critical limb ischemia (CLI). The study group included a sample of patients admitted to our diabetic foot unit because of a new diabetic foot ulcer and CLI. All subjects were managed using a limb salvage protocol which includes lower-limb revascularization. According to whether or not the revascularization procedure was a success, patients were respectively divided into two groups: successfully treated CLI patients (ST-CLI) and no-option CLI patients (NO-CLI). Failed revascularization was considered in the case of technical recanalization failure of occluded vessels (inability to overcome the obstruction) and/or absence of arterial flow to the foot. Limb salvage, major amputation, and death after 1 year of follow-up were evaluated and compared between the two groups. Overall, 239 patients were included, 74.9% belonging to ST-CLI and 25.1% to NO-CLI. NO-CLI patients reported more cases of ischemic heart disease (80 vs. 62.1, = 0.008), heart failure (63.3 vs. 32.4%, < 0.0001), and end-stage renal disease (ESRD) (60 vs. 25.7%) than ST-CLI patients. In addition, more vessels were affected in the NO-CLI group (5.2 ± 1.6 vs. 4 ± 1.5, < 0.0001), and there was more involvement of tibio-peroneal trunk (50 vs. 30.2%, = 0.006), anterior tibial (93.3 vs. 82.7, = 0.03), posterior tibial (93.3 vs. 73.7%, = 0.0005), peroneal (70 vs. 48%, = 0.002), and below-the-ankle arteries (73.3 vs. 39.1%, < 0.0001) than ST-CLI. The 1 year outcomes for the whole population were 69.9% limb salvage, 10.9% major amputation, and 19.2% death. The outcomes for NO-CLI and ST-CLI were, respectively, as follows: limb salvage (13.8 vs. 73.4%, < 0.0001), amputation (30 vs. 4.5%, = 0.0001), and mortality (50 vs. 8.9%, < 0.0001). NO-CLI patients showed a more severe pattern of peripheral arterial disease (PAD) with distal arterial lesions and worse outcomes than ST-CLI.

摘要

该研究旨在评估患有足部溃疡且无可选择的严重肢体缺血(CLI)的糖尿病患者的临床和血管特征以及预后情况。研究组包括因新发糖尿病足溃疡和CLI而入住我们糖尿病足治疗单元的患者样本。所有受试者均采用包括下肢血管重建术的保肢方案进行治疗。根据血管重建手术是否成功,患者被分别分为两组:成功治疗的CLI患者(ST-CLI)和无可选择的CLI患者(NO-CLI)。血管重建失败被定义为闭塞血管的技术再通失败(无法克服阻塞)和/或足部无动脉血流。对两组患者随访1年后的保肢情况、大截肢情况和死亡情况进行了评估和比较。总体而言,共纳入239例患者,其中74.9%属于ST-CLI组,25.1%属于NO-CLI组。与ST-CLI患者相比,NO-CLI患者报告的缺血性心脏病病例更多(80例对62.1例,P = 0.008)、心力衰竭更多(63.3%对32.4%,P < 0.0001)以及终末期肾病(ESRD)更多(60%对25.7%)。此外,NO-CLI组受影响的血管更多(5.2±1.6对4±1.5,P < 0.0001),胫腓干受累更多(50%对30.2%,P = 0.006)、胫前动脉受累更多(93.3%对82.7%,P = 0.03)、胫后动脉受累更多(93.3%对73.7%,P = 0.0005)、腓动脉受累更多(70%对48%,P = 0.002)以及踝以下动脉受累更多(73.3%对39.1%,P < 0.0001)。整个人群1年的预后情况为保肢率69.9%、大截肢率10.9%和死亡率19.2%。NO-CLI组和ST-CLI组的预后情况分别如下:保肢(13.8%对73.4%,P < 0.0001)、截肢(30%对4.5%,P = 0.0001)和死亡率(50%对8.9%,P < 0.0001)。与ST-CLI患者相比,NO-CLI患者表现出更严重的外周动脉疾病(PAD)模式,伴有远端动脉病变且预后更差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9de3/7700155/3863c3e0a093/jcm-09-03745-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9de3/7700155/3863c3e0a093/jcm-09-03745-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9de3/7700155/3863c3e0a093/jcm-09-03745-g001.jpg

相似文献

1
Characteristics and Outcome for Persons with Diabetic Foot Ulcer and No-Option Critical Limb Ischemia.糖尿病足溃疡合并无可选择的严重肢体缺血患者的特征及预后
J Clin Med. 2020 Nov 21;9(11):3745. doi: 10.3390/jcm9113745.
2
Use of Integra Dermal Regeneration Template for Limb Salvage in Diabetic Patients With No-Option Critical Limb Ischemia.Integra真皮再生模板在无可选择的严重肢体缺血糖尿病患者保肢中的应用
Int J Low Extrem Wounds. 2021 Jun;20(2):128-134. doi: 10.1177/1534734620905741. Epub 2020 Feb 14.
3
The impact of isolated tibial disease on outcomes in the critical limb ischemic population.孤立性胫骨疾病对严重肢体缺血人群治疗结果的影响。
Ann Vasc Surg. 2010 Apr;24(3):349-59. doi: 10.1016/j.avsg.2009.07.034. Epub 2010 Jan 4.
4
Prevalence of Peripheral Arterial Disease in Diabetic Foot Ulcer Patients and its Impact in Limb Salvage.糖尿病足溃疡患者外周动脉疾病的患病率及其对肢体保全的影响。
Int J Low Extrem Wounds. 2023 Sep;22(3):518-523. doi: 10.1177/15347346211027063. Epub 2021 Jun 18.
5
Subintimal angioplasty of infrapopliteal artery occlusions in the treatment of critical limb ischaemia. Short-term results.腘下动脉闭塞症的内膜下血管成形术治疗严重肢体缺血。短期结果。
Radiol Med. 2004 Sep;108(3):265-74.
6
Outcomes of angiosome and non-angiosome targeted revascularization in critical lower limb ischemia.关键下肢缺血中针对血管生成体和非血管生成体目标的血运重建的结果。
J Vasc Surg. 2013 Jan;57(1):44-9. doi: 10.1016/j.jvs.2012.07.042. Epub 2012 Oct 9.
7
Skin perfusion pressure measurement is valuable in the diagnosis of critical limb ischemia.皮肤灌注压测量在严重肢体缺血的诊断中具有重要价值。
J Vasc Surg. 1997 Oct;26(4):629-37. doi: 10.1016/s0741-5214(97)70062-4.
8
Clinical results of below-the knee intervention using pedal-plantar loop technique for the revascularization of foot arteries.采用足-足底环技术进行膝下干预以实现足部动脉血运重建的临床结果。
J Cardiovasc Surg (Torino). 2009 Jun;50(3):331-7.
9
Endovascular Distal Plantar Vein Arterialization in Dialysis Patients With No-Option Critical Limb Ischemia and Posterior Tibial Artery Occlusion: A Technique for Limb Salvage in a Challenging Patient Subset.腔内足底静脉远端动脉化治疗无选择重症肢体缺血合并胫后动脉闭塞的透析患者:一种治疗挑战性患者亚群肢体挽救的技术。
J Endovasc Ther. 2018 Feb;25(1):127-132. doi: 10.1177/1526602817750211. Epub 2017 Dec 21.
10
Severity of demographic and clinical characteristics, revascularization feasibility, major amputation, and mortality rate in diabetic patients admitted to a tertiary diabetic foot center for critical limb ischemia: comparison of 2 cohorts recruited at a 10-year distance.因严重肢体缺血入住三级糖尿病足中心的糖尿病患者的人口统计学和临床特征严重程度、血运重建可行性、大截肢率和死亡率:对相隔10年招募的两个队列的比较
Ann Vasc Surg. 2014 Oct;28(7):1729-36. doi: 10.1016/j.avsg.2014.06.004. Epub 2014 Jun 18.

引用本文的文献

1
Incidence and causes of major amputation in patients with diabetic foot ulcers: data from a retrospective study.糖尿病足溃疡患者大截肢的发生率及原因:一项回顾性研究的数据
Acta Diabetol. 2025 Sep 4. doi: 10.1007/s00592-025-02577-1.
2
Efficacy of autologous cell therapy on limb salvage in patients with chronic limb-threatening ischemia: 16-year single-center experience.自体细胞疗法对慢性肢体威胁性缺血患者保肢的疗效:16年单中心经验
Stem Cell Res Ther. 2025 Jul 15;16(1):362. doi: 10.1186/s13287-025-04493-1.
3
Predictive factors of major amputation in patients with diabetic foot ulcers treated by peripheral blood mononuclear cells.

本文引用的文献

1
Peripheral arterial disease in patients with renal-diabetic foot ulcers.患有肾性糖尿病足溃疡患者的外周动脉疾病。
J Wound Care. 2021 Aug 2;30(8):660-664. doi: 10.12968/jowc.2021.30.8.660.
2
Infrapopliteal Anatomic Severity and Delayed Wound Healing in Patients With Chronic Limb-Threatening Ischemia in the Era of the Global Limb Anatomic Staging System.全球肢体解剖分期系统时代慢性肢体威胁性缺血患者的腘下解剖严重程度与伤口愈合延迟
J Endovasc Ther. 2020 Aug;27(4):641-646. doi: 10.1177/1526602820933880. Epub 2020 Jun 17.
3
Prevalence, Clinical Aspects and Outcomes in a Large Cohort of Persons with Diabetic Foot Disease: Comparison between Neuropathic and Ischemic Ulcers.
外周血单个核细胞治疗糖尿病足溃疡患者大截肢的预测因素
Acta Diabetol. 2025 May 27. doi: 10.1007/s00592-025-02522-2.
4
Peripheral Arterial Disease in Diabetic Foot: One Disease with Multiple Patterns.糖尿病足中的外周动脉疾病:一种具有多种表现形式的疾病。
J Clin Med. 2025 Mar 14;14(6):1987. doi: 10.3390/jcm14061987.
5
Impacts of stem cells from different sources on wound healing rate in diabetic foot ulcers: a systematic review and meta-analysis.不同来源的干细胞对糖尿病足溃疡伤口愈合率的影响:一项系统评价和荟萃分析。
Front Genet. 2025 Jan 28;15:1541992. doi: 10.3389/fgene.2024.1541992. eCollection 2024.
6
The Immune-Centric Revolution Translated into Clinical Application: Peripheral Blood Mononuclear Cell (PBMNC) Therapy in Diabetic Patients with No-Option Critical Limb-Threatening Ischemia (NO-CLTI)-Rationale and Meta-Analysis of Observational Studies.以免疫为中心的革命转化为临床应用:外周血单个核细胞(PBMNC)疗法用于无可选择的严重肢体威胁性缺血(NO-CLTI)糖尿病患者——观察性研究的原理及荟萃分析
J Clin Med. 2024 Nov 28;13(23):7230. doi: 10.3390/jcm13237230.
7
Autologous cell therapy for ischemic diabetic foot: a meta-analysis of randomized controlled trials for the development of the Italian guidelines for the treatment of diabetic foot syndrome.缺血性糖尿病足的自体细胞治疗:一项关于制定意大利糖尿病足综合征治疗指南的随机对照试验的荟萃分析。
Acta Diabetol. 2024 Nov 15. doi: 10.1007/s00592-024-02393-z.
8
Effectiveness of autologous mononuclear cells as adjuvant therapy in patients with ischaemic diabetic foot ulcers receiving indirect lower limb revascularization.自体单核细胞作为辅助治疗对接受下肢间接血管重建术的缺血性糖尿病足溃疡患者的有效性。
Acta Diabetol. 2025 Apr;62(4):499-509. doi: 10.1007/s00592-024-02375-1. Epub 2024 Sep 17.
9
Sucrose Octasulfate-Impregnated Dressings for Adults With Difficult-to-Heal Noninfected Diabetic Foot Ulcers and Difficult-to-Heal Noninfected Venous Leg Ulcers: A Health Technology Assessment.蔗糖八硫酸酯浸渍敷料治疗成人难愈非感染性糖尿病足溃疡和难愈非感染性静脉性腿部溃疡:一项卫生技术评估。
Ont Health Technol Assess Ser. 2024 May 8;24(4):1-101. eCollection 2024.
10
Prostanoids in patients with diabetes and chronic limb-threatening ischemia: a meta-analysis of randomized clinical trials for the development of the Italian guidelines for the treatment of diabetic foot syndrome.糖尿病和慢性肢体威胁性缺血患者中的前列腺素:一项关于制定意大利糖尿病足综合征治疗指南的随机临床试验的荟萃分析
Acta Diabetol. 2024 Aug;61(8):1077-1080. doi: 10.1007/s00592-024-02260-x. Epub 2024 Apr 2.
大量糖尿病足病患者队列中的患病率、临床特征及预后:神经性溃疡与缺血性溃疡的比较
J Clin Med. 2020 Jun 8;9(6):1780. doi: 10.3390/jcm9061780.
4
Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update).《糖尿病足病预防与管理实用指南(IWGDF 2019 更新版)》
Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3266. doi: 10.1002/dmrr.3266.
5
Limb salvage in diabetic patients with no-option critical limb ischemia: outcomes of a specialized center experience.糖尿病患者无可选择的严重肢体缺血时的保肢治疗:一家专业中心的经验结果
Diabet Foot Ankle. 2019 Nov 28;10(1):1696012. doi: 10.1080/2000625X.2019.1696012. eCollection 2019.
6
Below-the-ankle arterial disease severely impairs the outcomes of diabetic patients with ischemic foot ulcers.踝以下动脉疾病严重影响伴有缺血性足部溃疡的糖尿病患者的预后。
Diabetes Res Clin Pract. 2019 Jun;152:9-15. doi: 10.1016/j.diabres.2019.04.031. Epub 2019 May 9.
7
BAD transmission and SAD distribution: a new scenario for critical limb ischemia.BAD传输与SAD分布:严重肢体缺血的新情况。
J Cardiovasc Surg (Torino). 2018 Oct;59(5):655-664. doi: 10.23736/S0021-9509.18.10572-6. Epub 2018 May 22.
8
Critical limb ischemia: current challenges and future prospects.严重肢体缺血:当前挑战与未来前景
Vasc Health Risk Manag. 2018 Apr 26;14:63-74. doi: 10.2147/VHRM.S125065. eCollection 2018.
9
Impact of heart failure and dialysis in the prognosis of diabetic patients with ischemic foot ulcers.心力衰竭和透析对糖尿病缺血性足溃疡患者预后的影响。
J Clin Transl Endocrinol. 2018 Mar 2;11:31-35. doi: 10.1016/j.jcte.2018.01.002. eCollection 2018 Mar.
10
Long term outcomes of diabetic haemodialysis patients with critical limb ischemia and foot ulcer.糖尿病合并严重肢体缺血和足部溃疡的血液透析患者的长期预后
Diabetes Res Clin Pract. 2016 Jun;116:117-22. doi: 10.1016/j.diabres.2016.04.030. Epub 2016 Apr 26.